Works matching IS 02692813 AND DT 2025 AND VI 61 AND IP 2

Results: 36

Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing? Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 400, doi. 10.1111/apt.18412
By:
- Park, Yewan;
- Jung, Jooyi;
- Kim, Gi‐Ae
Publication type:
Article
Editorial: Understanding Factors Associated With Abdominal Pain in Ulcerative Colitis—No Surprises But the Usual Suspects Need Greater Attention.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 371, doi. 10.1111/apt.18353
By:
- Gao, Weilun;
- Segal, Jonathan P.
Publication type:
Article
Letter: Should HBV Therapy Be Stopped Based on HBsAg Level Alone?
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 402, doi. 10.1111/apt.18407
By:
- Khan, Naeem A.;
- Shah, Syed B.;
- Choudhary, Umar I. J.;
- Ullah, A.;
- Ahmad, Saeed;
- Patwardhan, V.
Publication type:
Article
Editorial: Updated COVID‐19 Boosters—Tailoring Protection for Patients With IBD. Authors' Reply.
Published in:
2025
By:
- Woelfel, Simon;
- Brand, Stephan
Publication type:
Editorial
Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises the Importance of Appropriate Patient Selection and Centre Expertise.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 410, doi. 10.1111/apt.18411
By:
- Gao, Weilun;
- Segal, Jonathan P.
Publication type:
Article
Letter: Should HBV Therapy Be Stopped Based on HBsAg Level Alone? Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 404, doi. 10.1111/apt.18439
By:
- Johannessen, Asgeir;
- Reikvam, Dag Henrik;
- Dalgard, Olav
Publication type:
Article
Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises Importance of Appropriate Patient Selection and Centre Expertise—Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 412, doi. 10.1111/apt.18432
By:
- Bacsur, Péter;
- Farkas, Klaudia;
- Molnár, Tamás
Publication type:
Article
No Association Between Eosinophilic Oesophagitis and Oesophageal Cancer in US Adults: A Case–Control Study.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 363, doi. 10.1111/apt.18431
By:
- Albaneze, Natasha;
- Cotton, Cary C.;
- Anderson, Chelsea;
- Katzka, David A.;
- Dellon, Evan S.
Publication type:
Article
Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype? Authors' Reply.
Published in:
2025
By:
- Bacsur, Péter;
- Farkas, Klaudia;
- Molnár, Tamás
Publication type:
Editorial
Letter: Extending the Measurement of Inflammatory Bowel Disease Severity to Include Patient Important Outcomes—Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 408, doi. 10.1111/apt.18421
By:
- Swaminathan, Akhilesh;
- Sparrow, Miles P.;
- Gearry, Richard B.
Publication type:
Article
Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 258, doi. 10.1111/apt.18418
By:
- Chuah, Kee Huat;
- Loo, Qing Yuan;
- Hian, Wen Xuan;
- Khoo, Xin Hui;
- Panirsheeluam, Sarala;
- Jubri, Nurhidayah Binti Mohammad;
- Natarajan, Vicraman;
- Khoo, Stanley;
- Mahadeva, Sanjiv
Publication type:
Article
Letter: Extending the Measurement of Inflammatory Bowel Disease Severity to Include Patient Important Outcomes.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 406, doi. 10.1111/apt.18410
By:
- Forbes, Angela J.
Publication type:
Article
Early‐Life Infections, Antibiotics and Later Risk of Childhood and Early Adult‐Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 323, doi. 10.1111/apt.18358
By:
- Mårild, Karl;
- Lerchova, Tereza;
- Östensson, Malin;
- Imberg, Henrik;
- Størdal, Ketil;
- Ludvigsson, Johnny
Publication type:
Article
XBB.1.5‐Adapted COVID‐19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 299, doi. 10.1111/apt.18349
By:
- Woelfel, Simon;
- Dütschler, Joel;
- Junker, Daniel;
- König, Marius;
- Graf, Nicole;
- Krieger, Claudia;
- Truniger, Samuel;
- Oikonomou, Vasileios;
- Leinenkugel, Georg;
- Koller, Seraina;
- Metzger‐Peter, Katline;
- Wyss, Jacqueline;
- Krupka, Niklas;
- Frei, Nicola;
- Albrich, Werner C.;
- Friedrich, Matthias;
- Niess, Jan Hendrik;
- Schneiderhan‐Marra, Nicole;
- Dulovic, Alex;
- Misselwitz, Benjamin
Publication type:
Article
Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype?
Published in:
2025
By:
- McCurdy, Jeffrey D;
- Wong, Serre‐yu
Publication type:
Case Study
Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 313, doi. 10.1111/apt.18354
By:
- Hong, Sung Noh;
- Song, Joo Hye;
- Kim, Sung Jin;
- Park, Yoon Ha;
- Choi, Chang Wan;
- Kim, Ji Eun;
- Kim, Eun Ran;
- Chang, Dong Kyung;
- Kim, Young‐Ho
Publication type:
Article
Editorial: Rebuilding Rome—Revising Diagnostic Criteria for Irritable Bowel Syndrome.
Published in:
2025
By:
- Butt, Mohsin F.;
- Corsetti, Maura
Publication type:
Case Study
Letter: Integrating Psychological Profiles Into Dietary Interventions for IBS—Commentary on HADS Scores and Treatment Efficacy.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 396, doi. 10.1111/apt.18396
By:
- Chen, Chia‐Wei;
- Wei, Lien‐Chung
Publication type:
Article
Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter. Authors' Reply.
Published in:
2025
By:
- Yu, Jiong;
- Chen, Xinyi;
- Cao, Guoqiang;
- Pan, Qiaoling;
- Huang, Chenjie;
- Luo, Rui;
- Lu, Xiaoqing;
- Chen, Xiaoxiao;
- Li, Tan;
- Huang, Haijun;
- Wu, Jian;
- Li, Lanjuan;
- Cao, Hongcui
Publication type:
Editorial
Editorial: Is TIPSS Implantation Effective in Patients With Portal Hypertensive Gastropathy?
Published in:
2025
By:
- Reincke, Marlene;
- Thimme, Robert;
- Bettinger, Dominik
Publication type:
Editorial
Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Diseases.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 246, doi. 10.1111/apt.18390
By:
- Carbery, Isabel;
- Todd, Oliver;
- Hale, Matthew;
- Black, Christopher J.;
- Clegg, Andrew;
- Selinger, Christian P.
Publication type:
Article
Correction to 'Stromal Vascular Fraction With Platelet‐Rich Plasma Injection During Surgery is Feasible and Safe in Treatment‐Refractory Perianal Fistulising Crohn's Disease: A Pilot Study'.
Published in:
2025
Publication type:
Correction Notice
Editorial: Understanding Factors Associated With Abdominal Pain in Ulcerative Colitis—No Surprises but the Usual Suspects Need Greater Attention. Authors' Reply.
Published in:
2025
By:
- van Gils, Tom;
- Törnblom, Hans;
- Hreinsson, Jóhann P.;
- Jonefjäll, Börje;
- Strid, Hans;
- Simrén, Magnus
Publication type:
Editorial
Editorial: Updated COVID‐19 Boosters—Tailoring Protection for Patients With IBD.
Published in:
2025
By:
- Alexander, James L.;
- Caldera, Freddy
Publication type:
Case Study
Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing?
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 398, doi. 10.1111/apt.18375
By:
- Hu, Qiang;
- Yang, Xiyin
Publication type:
Article
Editorial: Disentangling Early‐Life Antibiotics and Infections as Risk Factors for the Development of Childhood IBD.
Published in:
2025
By:
- Stone, Katherine L.;
- Faye, Adam S.
Publication type:
Editorial
Letter: Insulin‐Like Growth Factor‐1 in Cirrhosis Is Linked to Hepatic Dysfunction and Fibrogenesis and Predicts Liver‐Related Mortality.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 394, doi. 10.1111/apt.18366
By:
- Tahir, Okasha;
- Rafique, Muhammad Muzamil;
- Khan, Abdul Ghani;
- Rajab, Asia;
- Alam, Umama;
- Umar, Muhammad;
- Shamim, Laiba;
- Hidayat, Ayesha
Publication type:
Article
Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 354, doi. 10.1111/apt.18363
By:
- Goodoory, Vivek C.;
- Riggott, Christy;
- Khasawneh, Mais;
- Black, Christopher J.;
- Ford, Alexander C.
Publication type:
Article
Portal Hypertensive Gastropathy and MELD‐Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 346, doi. 10.1111/apt.18362
By:
- Hu, Kelly;
- Sedki, Mai;
- Kwong, Allison;
- Kesselman, Andrew;
- Kolli, Kanti Pallav;
- Morelli, Giuseppe;
- Spengler, Erin;
- Said, Adnan;
- Lai, Jennifer;
- Desai, Archita;
- Paul, Sonali;
- Frenette, Catherine;
- Fallon, Michael;
- German, Margarita;
- Verna, Elizabeth;
- Boike, Justin;
- Gregory, Dyanna;
- Thornburg, Bartley;
- VanWagner, Lisa;
- Goel, Aparna
Publication type:
Article
Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter.
Published in:
2025
By:
- Russo, Francesco Paolo;
- Ferrarese, Alberto
Publication type:
Editorial
Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
Published in:
2025
By:
- Papamichael, Konstantinos;
- Cheifetz, Adam S.
Publication type:
Editorial
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 335, doi. 10.1111/apt.18359
By:
- Bacsur, Péter;
- Shaham, Daniel;
- Serclova, Zuzana;
- Resál, Tamás;
- Farkas, Bernadett;
- Sarlós, Patrícia;
- Miheller, Pál;
- Maharshak, Nitsan;
- Zemel, Meir;
- Shitrit, Ariella Bar‐Gil;
- Yellinek, Shlomo;
- Bálint, Anita;
- Fábián, Anna;
- Bor, Renáta;
- Bősze, Zsófia;
- Ivány, Emese;
- Szepes, Zoltán;
- Farkas, Klaudia;
- Tóth, Illés;
- Lázár, György
Publication type:
Article
aCCI‐HBV‐ACLF: A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 286, doi. 10.1111/apt.18347
By:
- Chen, Xinyi;
- Gao, Feiqiong;
- Pan, Qiaoling;
- Huang, Chenjie;
- Luo, Rui;
- Lu, Xiaoqing;
- Chen, Xiaoxiao;
- Li, Tan;
- Huang, Haijun;
- Wu, Jian;
- Yu, Jiong;
- Li, Lanjuan;
- Cao, Hongcui
Publication type:
Article
Factors Associated With Abdominal Pain in Patients With Active and Quiescent Ulcerative Colitis: A Multicohort Study.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 268, doi. 10.1111/apt.18344
By:
- van Gils, Tom;
- Törnblom, Hans;
- Hreinsson, Jóhann P.;
- Jonefjäll, Börje;
- Strid, Hans;
- Simrén, Magnus
Publication type:
Article
Issue Information.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 243, doi. 10.1111/apt.18070
Publication type:
Article
Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 278, doi. 10.1111/apt.18346
By:
- Tan, Darren Jun Hao;
- Tamaki, Nobuharu;
- Kim, Beom Kyung;
- Wijarnpreecha, Karn;
- Aboona, Majd Bassam;
- Faulkner, Claire;
- Kench, Charlotte;
- Salimi, Shirin;
- Sabih, Abdul‐Hamid;
- Lim, Wen Hui;
- Danpanichkul, Pojsakorn;
- Tay, Benjamin;
- Teh, Yiqing;
- Mok, John;
- Nah, Benjamin;
- Ng, Cheng Han;
- Muthiah, Mark;
- Kulkarni, Anand V.;
- Lee, Sung Won;
- Liu, Ken
Publication type:
Article